Enhanced anti-cancer activity of andrographis with oligomeric proanthocyanidins through activation of metabolic and ferroptosis pathways in colorectal cancer

Abstract The high degree of morbidity and mortality in colorectal cancer (CRC) patients is largely due to the development of chemoresistance against conventional chemotherapeutic drugs. In view of the accumulating evidence that various dietary botanicals offer a safe, inexpensive and multi-targeted...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tadanobu Shimura, Priyanka Sharma, Geeta G. Sharma, Jasjit K. Banwait, Ajay Goel
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/4a82efb76e0e40579a53168c121554d8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4a82efb76e0e40579a53168c121554d8
record_format dspace
spelling oai:doaj.org-article:4a82efb76e0e40579a53168c121554d82021-12-02T14:17:19ZEnhanced anti-cancer activity of andrographis with oligomeric proanthocyanidins through activation of metabolic and ferroptosis pathways in colorectal cancer10.1038/s41598-021-87283-y2045-2322https://doaj.org/article/4a82efb76e0e40579a53168c121554d82021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-87283-yhttps://doaj.org/toc/2045-2322Abstract The high degree of morbidity and mortality in colorectal cancer (CRC) patients is largely due to the development of chemoresistance against conventional chemotherapeutic drugs. In view of the accumulating evidence that various dietary botanicals offer a safe, inexpensive and multi-targeted treatment option, herein, we hypothesized that a combination of Andrographis paniculata and Oligomeric Proanthocyanidins (OPCs) might interact together with regard to anti-tumorigenic activity in CRC. As a result, we demonstrated the enhanced anti-cancer activity between these two botanical extracts in terms of their ability to inhibit cancer cell growth, suppress colony formation and induce apoptosis. Furthermore, we validated these findings in subcutaneous xenograft model and in patient derived primary epithelial 3D organoids. Transcriptomic profiling identified involvement of metabolic pathways and ferroptosis-associated genes, including HMOX1, GCLC and GCLM, that may be responsible for the increased anti-tumorigenic activity by the two compounds. Collectively, our study provides novel evidence in support of the combinatorial use of andrographis and OPCs as a potential therapeutic option, perhaps as an adjunctive treatment to classical drugs, in patients with colorectal cancer.Tadanobu ShimuraPriyanka SharmaGeeta G. SharmaJasjit K. BanwaitAjay GoelNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Tadanobu Shimura
Priyanka Sharma
Geeta G. Sharma
Jasjit K. Banwait
Ajay Goel
Enhanced anti-cancer activity of andrographis with oligomeric proanthocyanidins through activation of metabolic and ferroptosis pathways in colorectal cancer
description Abstract The high degree of morbidity and mortality in colorectal cancer (CRC) patients is largely due to the development of chemoresistance against conventional chemotherapeutic drugs. In view of the accumulating evidence that various dietary botanicals offer a safe, inexpensive and multi-targeted treatment option, herein, we hypothesized that a combination of Andrographis paniculata and Oligomeric Proanthocyanidins (OPCs) might interact together with regard to anti-tumorigenic activity in CRC. As a result, we demonstrated the enhanced anti-cancer activity between these two botanical extracts in terms of their ability to inhibit cancer cell growth, suppress colony formation and induce apoptosis. Furthermore, we validated these findings in subcutaneous xenograft model and in patient derived primary epithelial 3D organoids. Transcriptomic profiling identified involvement of metabolic pathways and ferroptosis-associated genes, including HMOX1, GCLC and GCLM, that may be responsible for the increased anti-tumorigenic activity by the two compounds. Collectively, our study provides novel evidence in support of the combinatorial use of andrographis and OPCs as a potential therapeutic option, perhaps as an adjunctive treatment to classical drugs, in patients with colorectal cancer.
format article
author Tadanobu Shimura
Priyanka Sharma
Geeta G. Sharma
Jasjit K. Banwait
Ajay Goel
author_facet Tadanobu Shimura
Priyanka Sharma
Geeta G. Sharma
Jasjit K. Banwait
Ajay Goel
author_sort Tadanobu Shimura
title Enhanced anti-cancer activity of andrographis with oligomeric proanthocyanidins through activation of metabolic and ferroptosis pathways in colorectal cancer
title_short Enhanced anti-cancer activity of andrographis with oligomeric proanthocyanidins through activation of metabolic and ferroptosis pathways in colorectal cancer
title_full Enhanced anti-cancer activity of andrographis with oligomeric proanthocyanidins through activation of metabolic and ferroptosis pathways in colorectal cancer
title_fullStr Enhanced anti-cancer activity of andrographis with oligomeric proanthocyanidins through activation of metabolic and ferroptosis pathways in colorectal cancer
title_full_unstemmed Enhanced anti-cancer activity of andrographis with oligomeric proanthocyanidins through activation of metabolic and ferroptosis pathways in colorectal cancer
title_sort enhanced anti-cancer activity of andrographis with oligomeric proanthocyanidins through activation of metabolic and ferroptosis pathways in colorectal cancer
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/4a82efb76e0e40579a53168c121554d8
work_keys_str_mv AT tadanobushimura enhancedanticanceractivityofandrographiswitholigomericproanthocyanidinsthroughactivationofmetabolicandferroptosispathwaysincolorectalcancer
AT priyankasharma enhancedanticanceractivityofandrographiswitholigomericproanthocyanidinsthroughactivationofmetabolicandferroptosispathwaysincolorectalcancer
AT geetagsharma enhancedanticanceractivityofandrographiswitholigomericproanthocyanidinsthroughactivationofmetabolicandferroptosispathwaysincolorectalcancer
AT jasjitkbanwait enhancedanticanceractivityofandrographiswitholigomericproanthocyanidinsthroughactivationofmetabolicandferroptosispathwaysincolorectalcancer
AT ajaygoel enhancedanticanceractivityofandrographiswitholigomericproanthocyanidinsthroughactivationofmetabolicandferroptosispathwaysincolorectalcancer
_version_ 1718391603791396864